Skip to main content

ORIGINAL RESEARCH article

Front. Genet., 29 April 2021
Sec. RNA
Volume 12 - 2021 | https://doi.org/10.3389/fgene.2021.616220
This article is part of the Research Topic RNA Modification in Human Cancers: Roles and Therapeutic Implications View all 48 articles

RETRACTED: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer

Retracted

A retraction of this article was approved in:

  1. Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer

    1. Read retraction
\r\nXinzhuan JiaXinzhuan Jia1Lan WeiLan Wei2Zhengmao Zhang*Zhengmao Zhang3*
  • 1Department of Reproductive Medicine, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China
  • 2Department of Chest Surgery, Hebei Chest Hospital, Shijiazhuang, China
  • 3Department of Gynecology, The Fourth Hospital, Hebei Medical University, Shijiazhuang, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Jia X, Wei L and Zhang Z (2021) NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer. Front. Genet. 12:616220. doi: 10.3389/fgene.2021.616220

Received: 11 October 2020; Accepted: 27 January 2021;
Published: 29 April 2021; Retracted: 31 January 2022.

Edited by:

Jing Sun, George Washington University, United States

Reviewed by:

Haixiang Yu, Duke University, United States
Oscar Gee Wan Wong, The University of Hong Kong, Hong Kong

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.